Inspire Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Inspire Advisors’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-14,495	Closed	-$614K	–	488
2024 Q1	$614K	Buy	14,495 +813	+6%	+$34.2K	0.08%	166
2023 Q4	$572K	Buy	13,682 +2,987	+28%	+$110K	0.09%	154
2023 Q3	$403K	Sell	10,695 -2,603	-20%	-$97.7K	0.07%	157
2023 Q2	$504K	Buy	13,298 +2,919	+28%	+$91.6K	0.1%	96
2023 Q1	$252K	Buy	10,379 +2,564	+33%	+$74.8K	0.06%	151
2022 Q4	$227K	Buy	7,815 +913	+13%	+$27.1K	0.06%	145
2022 Q3	$207K	Buy	+6,902	New	+$238K	0.06%	119
2021 Q1	–	Sell	-1,108	Closed	-$81K	–	773
2020 Q4	$81K	Buy	+1,108	New	+$71.2K	0.03%	158

Other funds holding TARO

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

AIIMS

Analyst IMS Investment Management Services Tel-Aviv, Israel $3.3B AUM 20.27% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return

GCM

Gladius Capital Management Chicago, Illinois $2.24B AUM 23.45% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Inspire Advisors's TARO Position: Q2 2024 in Review

Inspire Advisors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 14,495 shares — an estimated $614K sold.

Inspire Advisors first reported a position in TARO in Q4 2020 and held it in 8 quarters. The position peaked at $614K in Q1 2024. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

Inspire Advisors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
Inspire Advisors sold 14,495 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $614K.
Inspire Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2020 and held it in 8 quarters.
Inspire Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $614K in Q1 2024.
16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on Inspire Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.